MSC Isolation via CD146 and NG2 Markers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack standardized procedures to isolate multipotent Mesenchymal Stem Cells (MSCs) with specific immunophenotypes indicative of potency, leading to variability in regenerative capacity and therapeutic efficacy across different donors and culture conditions, hindering the therapeutic potential of MSCs in regenerative medicine.
Innovation Solution
The method involves using antibodies targeting CD146 and NG2 antigens conjugated with indicators to selectively identify and isolate MSCs with high expression of these markers through flow cytometry or other techniques, minimizing cell damage and enabling the selection of cells with high proliferation potential and multipotency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional MSC identification methods are used, then MSCs can be obtained from heterogeneous cultures, but the regenerative capacity and therapeutic efficacy vary significantly due to heterogeneity in progenitor content
Solution Approach 1:
The patent applies local quality by using specific immunophenotypic markers (CD146, NG2, CD271) to identify and isolate cells with specific properties (high proliferation potential and multipotency) from the heterogeneous MSC population. This allows selective enrichment of cells with desired characteristics rather than treating all MSCs uniformly.
Solution Approach 2:
The patent changes the identification parameters from conventional markers to specific immunophenotypic markers (CD146, NG2, CD271) that correlate with high proliferation potential and multipotency. This parameter change enables more reliable isolation of cells with consistent therapeutic properties.
2Measurement precision
If flow cytometry with multiple markers is used to identify multipotent MSCs, then isolation precision improves, but device complexity and procedural complexity increase
Solution Approach 1:
The patent focuses on specific local qualities (immunophenotypic markers) that are most predictive of multipotency and proliferation potential, rather than analyzing all possible cell surface markers. This targeted approach maintains precision while reducing complexity.
Solution Approach 2:
The patent changes the selection criteria to specific immunophenotypic profiles (e.g., CD146+, NG2+, CD271+) that have been shown to correlate with high proliferation potential and multipotency. This parameter optimization achieves high identification accuracy with a manageable number of markers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the efficient identification and isolation of MSCs with high colony-forming efficiency and multipotency, enhancing their therapeutic potential by minimizing senescent cells and promoting consistent regenerative outcomes across various applications, including autologous and allogenic therapies.
Implementation Method 1
Antibodies targeting CD146 and NG2 antigens conjugated with indicators are used to selectively identify and isolate MSCs with high expression of these markers
Data Source
AI summary
Variations in the differentiation and lineage potential of stem cells, including mesenchymal stem cells, currently limit their therapeutic use. The ability to identify, isolate, and specifically amplify stem cell populations with desired differentiation potential would contribute the use of stem cells in research and therapy. The present invention discloses a method of assessing differentiation potential of stem cells by measuring the differential expression of antigens CD 146 and NG2 on the stem cells. The correlation between CD 146 and NG2 expression and differentiation and trilineage potential is explored. The invention also discloses methods to specifically amplify or enrich stem cells with desired differentiation potential, monitor the differentiation potential of a heterogeneous stem cell population, quantify the heterogeneity in differentiation potential of a stem cell culture, and remove stem cells with specific differentiation potentials from a heterogeneous cell culture.